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Dear Editor,
Nephrotic syndrome (NS) is a common disorder of childhood.
The risk of thromboembolic (TE) phenomena in children with
NS is estimated as 1.8–5% with a higher incidence in steroid
resistant forms.1,2
Venous thrombosis is the most frequent type of thrombo-
sis in childhood NS and occurs mainly in the deep venous
system.3 Kerlin et al.4 reported 39 TE events among 326
NS patients and 29 of them were deep venous thromboses
majority of which were seen in lower extremities. Although
infrequent other sites like the cerebral venous system may
also be affected and this presentation carries increased mor-
bidity and mortality. Herein we present two children with
minimal change disease (MCD) who experienced thrombosis
of the cerebral sinovenous system.
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Patient 1
A 15-year-old boy was admitted to our clinic with edema
and 10kg weight gain in a month. Physical examination
(PE) showed generalized edema and ascites. Urinary exam-
ination showed 246mg/m2/h proteinuria. Serum albumin
level was 0.8 g/dl, cholesterol and triglyceride levels were
375mg/dl and 190mg/dl respectively. Hemoglobin (Hb) level
was 16.2 g/dl. Renal biopsy was compatible with MCD. He was
put on 60mg/day prednisone treatment and remission was
achieved on the 22nd day. Steroid was used as 60mg/day for
a month and tapered over 3 months. The day after cessa-
tion of prednisone generalized edema, headache and vomiting
started. Laboratory investigations showed severe protein-
uria, 1060mg/m2/h and a serum albumin of 0.8 g/dl. His Hb
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Fig. 1 – Cranial MR on admission; superior sagittal sinus (A) and right transverse sinus (B) thrombosis (arrows). Follow-up
MR angiography (C, D); sinuses are partially recanalized with persistant hypointense thrombotic ﬁlling defects (arrows).
level was 21.6 g/dl and hematocrit (htc) 63.8%. He was put
back on 60mg/day prednisone and intravenous ﬂuid, albu-
min replacement, acetylsalicylic acid therapy were started.
Cranial computed tomography (CT) was normal. Next day
PE revealed lateral gaze palsy of the right eye. Cranial mag-
netic resonance imaging (MRI) andMR venography (MRV)were
performed which showed subacute superior sagittal, right
sigmoid and transverse sinus thromboses (Fig. 1A and B).
Immediate anticoagulation with heparin was started. Inves-
tigations for inherited thrombotic risk factors were negative.
On the third day of admission lateral gaze became normal.
Two weeks later a repeat MRV showed partial recanaliza-
tion of the thrombi (Fig. 1C and D). Remission of NS was
achieved on the 35th day of steroid treatment, then the
dose was decreased and the patient was put on cyclosporine.
He had complete neurological recovery and did not expe-
rience recurrence of NS or thrombosis during the two-year
follow-up.
Patient 2
A 2.5-year-old boy with no signiﬁcant past medical history
presented to our clinic with pufﬁness of the eyelids, edema
of legs and decreased urine output. He had gained 2kg of
weight in a week time. Physical examination revealed facial
and pitting edema on extremities in addition to abdomi-
nal distension. Laboratory investigations showed Hb 14.9 g/dl,
htc 45.9%, platelet count 406,000/L, total protein 3.7 g/dl,
albumin 1.4 g/dl, serum cholesterol 382mg/dl and normal
renal function tests. Urinary examination revealed heavy pro-
teinuria; 244mg/m2/h. Serum C3 and C4 levels were normal.
Nephrotic syndrome was diagnosed and the patient was put
on 2mg/kg prednisone treatment. On the 4th day of treatment
the patient complained of headache. Cranial CT was normal.
On the 5th dayhe developed right 6th cranial nerve palsy.Mag-
netic resonance imaging and MRV showed thromboses in the
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Fig. 2 – Coronal T2-weighted (A) and transverse T1-weighted (B) MR images show hyperintense thrombus in transverse and
sigmoid sinuses (arrows). Contrast-enhanced MR angiography axial (C) and sagittal (D) reformatted images demonstrate
thrombus as hypointense ﬁlling defects in right transverse sinus (curved-arrows).
superior sagittal, right transverse and sigmoid sinuses extend-
ing into the jugular system (Fig. 2). Intravenous hydration,
low molecular weight heparin (LMWH) were started imme-
diately. Screening for inherited thrombophilias was negative.
On 10th day patient’s headache subsided, focal neurologi-
cal signs resolved. Remission was achieved on the 14th day
of steroid treatment. The patient was discharged on steroid
and LMWH. He had complete neurological recovery and
has not experienced any complication during follow-up for
6 months.
Discussion
Cerebral sinovenous thrombosis is a rare but serious compli-
cation of NS with few isolated reports in the literature. Its
incidence in children has been reported as 0.67/100.000 by the
Canadian registry.5 Themost frequent site reported for throm-
bus in CSVT patients is the superior sagittal sinus followed by
the straight and the transverse sinuses.6 Appropriate imaging
is necessary for timely diagnosis. In daily practice cranial CT
is usually the preferred modality; however, it may miss CSVT
in nearly 40% of patients.5 Magnetic resonance imaging with
MRV is considered as the best method for the diagnosis and
follow-up of pediatric CSVT.6
The hypercoagulable state in NS is due to several potential
mechanisms; urinary loss of anticoagulant proteins, espe-
cially antithrombin (AT) III, increased procoagulatory activity,
increased platelet aggregation and thrombocytosis.7 Hyper-
lipidemiamayalsobeanadditive factor.1 Other factors include
hemoconcentration, diuretic use, severe hypoalbuminemia
and indwelling catheters. Thrombosis in NS is mainly a
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secondary phenomenon but all children should be checked
for hereditary thrombotic disorders. Our patients had no fam-
ily history for TE events and thrombophilia panel testing was
negative in both. Kerlin et al.4 recently reported TE events
in 6.6% of patients with primary NS and showed severity of
proteinuria, adolescent age (>12 years), and history of TE dis-
ease correlate well with TE risk. Our patients had MCD with
heavy proteinuria and very low serum albumin levels dur-
ing the attack. Hemoconcentration was a striking ﬁnding in
one of our patients. The ﬁrst patient was an adolescent; how-
ever, the second case was a 2.5-year-old boy. Thromboembolic
complications are known to be more prevalent early in the dis-
ease course.8 A median time of 70.8 days from NS diagnosis to
the ﬁrst TE is recently reported in concordance with previous
reports, 61% of the events occurring in the ﬁrst 3 months just
as in our patients.4
In the absence of major intracranial hemorrhage antico-
agulation therapy is the preferred treatment in children with
CSVT.9 There is no current consensus over the prophylactic
use of anticoagulation and in daily practice it is not used
unless patient has a thrombosis history.
Our cases highlight the importance of clinical suspicion
and early diagnosis in NS patients with any neurological
symptom.Careful physical examination, appropriate imaging,
acute anticoagulation and proper treatment of the NS would
reduce morbidity and prevent life threatening complications.
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